ASCO Education
American Society of Clinical Oncology (ASCO)
ASCO Education: By the Book features engaging discussions between editors and authors from the ASCO Educational Book. Hear nuanced views on topics featured in Education Sessions at ASCO meetings and deep dives on the approaches shaping modern oncology that have care teams talking.
Episodes
Mentioned books
Dec 13, 2017 • 4min
Self-Evaluation: Metastatic Breast Cancer
Dr. Aditya Bardia, attending physician at the Massachusetts General Hospital Cancer Center, presents a self-evaluation question on the treatment of metastatic breast cancer.
Dec 6, 2017 • 5min
ASCO Guidelines: Systemic Therapy for Stage IV Non-Small-Cell Lung Cancer Update
Dr. Gregory Riely, medical oncologist at Memorial Sloan Kettering Cancer Center in New York City, presents the ASCO Guideline update on Systemic Therapy for Stage IV Non-Small-Cell Lung Cancer, published in the Journal of Clinical Oncology in August 2017.
Nov 22, 2017 • 8min
Recently Approved Drugs: Nivolumab for Metastatic Colorectal Cancer
Dr. Matthew Yurgelun, assistant professor of medicine at Harvard Medical School and gastrointestinal medical oncologist at the Dana Farber Gastrointestinal Cancer Center and Cancer Genetics and Prevention Program, presents information on the recently approved nivolumab for the treatment of patients 12 years and older with mismatch repair deficient and microsatellite instability high metastatic colorectal cancer.
Nov 15, 2017 • 4min
Self-Assessment: Metastatic Prostate Cancer
Dr. Janice Dutcher, Associate Director of the Cancer Research Foundation of New York and medical oncology co-chair of the NCI Renal Cancer Task Force, presents a self-assessment question on the treatment of castrate-resistant metastatic prostate cancer.
Nov 11, 2017 • 5min
Recently Approved Drugs: Pembrolizumab for cHL
Dr. Christina Wiedl, director of the pediatric and young adult stem cell transplant program at Virginia Commonwealth University, presents information on the recently approved drug in oncology, keytruda for relapsed and refractory classical Hodgkin lymphoma in pediatric and young adult patients.
Nov 8, 2017 • 8min
ASCO Guidelines: Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer
Dr. Josh Lauring, Assistant Professor of Oncology at the Sidney Kimmel Cancer Center at John's Hopkins, presents the joint ASCO/AMP Guideline on Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in cancer, published in the Journal of Molecular Pathology in January 2017.
Oct 11, 2017 • 5min
ASCO Guidelines: Management of Small Renal Masses
Dr. Ornob Roy, Urologist with Carolinas Healthcare Systems, presents the ASCO Guideline on Management of Small Renal Masses, originally published in the Journal of Clinical Oncology in January 2017.
Aug 9, 2017 • 5min
ASCO Guidelines: Potentially Curable Pancreatic Cancer
Dr. Alok Khorana, medical oncologist and professor of medicine at the Cleveland Clinic, presents the recently published ASCO Guideline on potentially curable pancreatic cancer.
Jul 19, 2017 • 6min
ASCO Guidelines: Secondary Prevention of Cervical Cancer
Dr. Philip Castle, Professor in the Department of Epidemiology and Population Health at Albert Einstein College of Medicine, presents the ASCO Guideline on Secondary Prevention of Cervical Cancer, originally published in the Journal of Clinic Oncology in October 2016.
Jun 28, 2017 • 5min
ASCO Guidelines: Prevention and Monitoring of Cardiac Dysfunction in Survivors of Adult Cancers
Saro H. Armenian, D.O., MPH, pediatric hematologist/oncologist at City of Hope, presents the ASCO Guideline on prevention and monitoring of cardiac dysfunction in survivors of adult cancers, originally published in the Journal of Clinical Oncology in March 2017.
